The notion that autoimmune mechanisms play a role in the pathogenesis of 
Behcet's disease, a systemic disorder, is the leading cause of endogenous uveitis in Japan.' Uveitis is the most serious clinical finding and is responsible for 10-15% ofthe acquired blindness in Japan. ' The mechanisms of the ocular inflammation are still controversial.
Several lines of evidence support a significant role for autoreactive T lymphocytes in mediating ocular inflammation. Immunisation with retinal S antigen or interphotoreceptor retinoid binding protein -(IRBP) causes an experimental autoimmune uveoretinitis (EAU) that resembles some human uveitic conditions.2`5 In vivo or in vitro sensitised, S antigen or IRBP specific T cells transferred to naive animals induce EAU. 6 7 Cultures were set up in triplicate consisting of 2 x 10' cells/well, incubated for 5 days in flat bottom, 96 well microplates, at 37°C with 100% humidity and 5% carbon dioxide in air. The retinal antigens were added at the concentrations of 4, 20, or 100 gg/ml. Cultures were pulsed for the last 16 hours with tritiated thymidine ('H-TdR, New England Nuclear, Boston, MA; 2 Ci/mmol, 0-5 ,uCi per 20 ul/well) and the incorporated radioactivity was counted by a liquid scintillation counter. Several antigens were tested simultaneously. However, not all antigens could be tested on every patient or control owing to the small amount of blood available and the number of mononuclear cells that could be recovered.
The results were expressed as disintegrations per minute (dpm) In a preliminary study on the kinetics and on the dose response of the proliferative responses to bovine S antigen and bovine IRBP, peak responses were seen in cultures after 5 days of incubation with S antigen at 4 ,ug/ml and IRBP at 20 ,ug/ml. Therefore, these culture conditions were used for the following analysis. As for the lymphocyte proliferative responses, the responses to S antigen (SI) were significantly higher in patients with Behcet's disease with uveitis, mean 8 1 (SE , than in those without uveitis, 1-6 (0 7) (p<0 05), or in the controls, 1-6 (0 9) (p<0 05) (Fig IA) . For IRBP, the responses were significantly higher in patients with Behcet's disease with uveitis, 5 1 (5 9) compared with the controls, 1-4 (1-4) (p<005) (Fig 2A) . Responses to IRBP in patients with Behcet's disease without uveitis, 2-3 (1-6), were not as high as those observed in patients with uveitis (Fig 2A) . Based on the incidence of responders, 14 out of 23 (61%) patients with Behcet's disease with uveitis responded to S antigen, while only five of Table 2) . Among the patients and control subjects shown in Table 1 , 22 patients with Behcet's disease with uveitis, 17 without uveitis, and 21 control subjects were tested concomitantly with S antigen and IRBP. The group of responders to at least one of the antigens were 14 of 22 patients with Behcet's disease with uveitis (64%), nine of 17 patients without uveitis (53%), and eight of21 control subjects (38%). In this population, 64% of patients with uveitis responded to both antigens, while only 22% of patients without uveitis,and 28% of control subjects responded to them.
Still considering the population of patients with uveitis tested with S antigen and IRBP concomitantly (n=22) and comparing patients with active uveitis and those with inactive uveitis in respect of their responses to S antigen and/or IRBP, in the group with active uveitis (n= 10), nine responded to S antigen, of whom five also responded to IRBP, and one did not respond to either antigen. In contrast, in the group with inactive uveitis (n= 12), four responded to S antigen, these same four patients plus one 37 (19%) responded to peptide M, peptide N, R-4, and R-14, respectively (Table 2) . Similarly, among patients without uveitis, 16 of 17 (94%), 13 of 17 (76%), 10 of 17 (59%), and seven of 17 (41%) responded to the respective peptides ( Table 2 ). The incidences of responders to the respective peptides in the control group were seven of21 (33%), eight of 20 (40%), three of 14 (21%), and three of 21 (21%) ( Table 2) . A statistical significance was observed between the incidence of responders to peptide M in patients without uveitis compared with the controls (p<0-01).
Considering the patients tested concomitantly with the native protein and its respective uveitogenic peptides, among the 11 patients with Behcet's disease with uveitis who responded to S antigen, nine also responded to peptide M (82%), and five responded to peptide N (45%). All five patients without uveitis who responded to S antigen also responded to peptide M and peptide N. In respect of IRBP, among six patients with Behcet's disease with uveitis who responded to IRBP, three responded to R-4 (50%) and two to R-14 (33%). Of six patients with Behcet's disease without uveitis who responded to IRBP, five also responded to R-4 (83%) and six to R-14 (100% The study of the inhibition of the lymphocyte proliferative responses to the antigens with mAbs was performed in responders to peptide M with Behcet's disease with (n=3) and without (n=3) uveitis. Figure 3 shows four representative cases ofpatients with Behcet's disease, two with uveitis ( Fig 3A and 3C) , and two without uveitis (Fig 3B  and 3D ). MAbs anti-CD4 and anti-DR inhibited all responses. MAbs anti-CD3 and anti-T cell accessory molecules CD2 and LFA-1 also inhibited the responses. Responses of some patients were further inhibited by mAb anti-CD8. The responses of both groups of patients with Behcet's disease were inhibited in a similar way.
Discussion
The presence of cellular proliferative response to S antigen has been described in various uveitic conditions."'2 Faure et al24 reported a high frequency of positive responses to S antigen among patients with Behcet's disease with uveitis using a leucocyte migration inhibition test. In the present study, patients with Behcet's disease with uveitis showed significant high responses and a high number of positive responders to both the retinal specific antigens, S antigen and IRBP. The responsiveness to S antigen was mostly observed in patients with Behcet's disease with active uveitis, in young patients, and in patients with uveitis of short duration. The findings that several patients from both groups with Behcet's disease responded to IRBP derived peptides, R-4 and/or R-14, but did not recognise IRBP itself may indicate that these peptides are 'cryptic determinants.'29 Further, the non-responsiveness to S antigen but responsiveness to peptide M of patients with Behcet's disease without uveitis could be due to the differences in the fragments expressed when bovine S antigen is cleaved and when peptide M is cleaved.3" However, the non-responsiveness to S antigen cannot be ignored but responsiveness to peptide M could be due to the differences in molar concentration between them. Peptide N evoked responses in lymphocytes from only patients with Behcet's disease without uveitis, therefore, it could be speculated that it is involved in some suppressive mechanism that impedes the manifestation of the eye inflammation.
In spite of the extensive cross-reactivity and similarities of bovine S antigen and human S antigen32 and of bovine IRBP and human IRBP,33 and the similarities between the responses to human and bovine S antigen tested simultaneously by Nussenblatt et al,8 several of the differences observed between the patients with uveitis and those without uveitis could in part be related, to the bovine source of the antigens.3' Intraocular inflammation may increase the number of circulating clones to less frequent peptide determinants and these may manifest themselves as a response to bovine S antigen or IRBP.
The study on the inhibition of the lymphocyte proliferative responses to peptide M showed that the surface molecules involved in the T cell activation in vitro were similar in both groups of patients with Behcet's disease, with uveitis and without uveitis. CD4+ T cells, as well as antigen presenting cells (APCs) with HLA-DR molecules, were revealed to be important in the lymphocyte proliferative responses in all patients tested. These findings are consistent with the reports about the importance of CD4+ T cells,67 and the presence ofIa+ cells3' in the induction of EAU. Expression of MHC class II antigens in both the infiltrating cells and ocular resident cells has also been described in enucleated eyes from uveitis patients. 35 
